The combination of i-leader truncation and gemcitabine improves oncolytic adenovirus efficacy in an immunocompetent model.
about
The combination of i-leader truncation and gemcitabine improves oncolytic adenovirus efficacy in an immunocompetent model.
description
2014 nî lūn-bûn
@nan
2014年の論文
@ja
2014年論文
@yue
2014年論文
@zh-hant
2014年論文
@zh-hk
2014年論文
@zh-mo
2014年論文
@zh-tw
2014年论文
@wuu
2014年论文
@zh
2014年论文
@zh-cn
name
The combination of i-leader tr ...... y in an immunocompetent model.
@en
The combination of i-leader tr ...... y in an immunocompetent model.
@nl
type
label
The combination of i-leader tr ...... y in an immunocompetent model.
@en
The combination of i-leader tr ...... y in an immunocompetent model.
@nl
prefLabel
The combination of i-leader tr ...... y in an immunocompetent model.
@en
The combination of i-leader tr ...... y in an immunocompetent model.
@nl
P2093
P2860
P356
P1433
P1476
The combination of i-leader tr ...... y in an immunocompetent model.
@en
P2093
A Rodríguez-García
C Puig-Saus
M Cascalló
P2860
P2888
P356
10.1038/CGT.2013.85
P577
2014-01-17T00:00:00Z
P6179
1037558058